He posted news on NK trial which isnt due till sept. He has only posted that one time. Cant find anything to support that post. Stock had no reaction at all. JJ has not PR'd, and you know he would. As sno says, not on clinical gov site. Not on Gtree english webpage.
You cant stop bashing JJ? What purpose does this serve to say the same thing everyday?. It certainly is not the type of post that fits with a long agenda. Again, sno's bizzare money losing agenda is only known to him. Only one thing is certain, he will repeat the same message over and over..........................
Sno says he bought at the offer of 50 about a week ago. But, doesnt see the value now paying the .395 offer? Nothing has changed in this last week. But his posts since the "50 cent purchase" have become decidedly negative. This is classic Sno...................lol[
Yes, elephant in the room for sure, but its not patents, its the Donk who miraculously appears after a long absence on the day the stock is attacked by the shorts. What a coincidence. And he appears to enlighten us, once again, on a patent problem. A problem that neither china(delay from manufacturing issues; china is a dysfuntional partner at best) nor Korea seemed concerned about.
Sept here soon enough, along with details of Korean trials. Buy the weakness..............right sno????? No, better to wait when all details are positively known. Buy high, Now thats investing.........
Free advice from expert donk is worth exactly what it costs. Keep up the good work donk. See you at a buck
Koreans and Chinese should have consulted with Donk & Donk before commiting to TB4 and RGRX.
Gtree has bet their whole existence on TB4 and gotten miilions from the Korean government, but will lose all because they did not consult with expert message board patent attorney..... the donk
When will they learn..........................?
The liver is a huge potential market. Nonalcoholic steatohepatitis and other diseases of the liver characterized by tissue fibrosis is mostly unmet right now. The fatty liver diseases has no treatment, other than diet, but most americans just cant do that. So 2 bios with no revs have some potential in the liver area and have on going trials only; ICPT(market cap 4.6 BILLION) and LJPC(market cap 1/2 Billion). As always, great potential with rgrx
Sno, thats about the 100th post saying the same thing. Again, we get it, you are worried. Nobody cares about your anxieties. You didnt seem to have any at 50 cents(your last purchase; or so you say). Why do you feel it necessary to display your obsessive compulsions endlessly here. Give us a break and take a couple valium and disappear for a while.
Again sno's implied negative bias, along with his "purchases", point to very good things ahead. This is the same guy who was bashing the stock, and didnt see the risk/reward at a dime.L0l Yea, i might listen to his concerns.............................................
You are a real peice of work. You posted(and have since removed) your buying at .5. Made note of it and even e mailed b7 on your posted buy, as i am still amazed that you would pay the offer at the time when you can buy plenty on the bid till news comes out.
Between your failed track record and your strange agenda and now your dishonest posts, all should read your posts for entertainment ONLY.
LYING? For someone who thinks he is so smart, you aint. B7 talks his book, and his position is real.
Sno, lies about his buying, removes post on same as well as his comments about rgrx getting put in a bio index.Who pumped china more than he? And you have no problem with that.
Donk cant even write a post that anyone can understand. He wants everyone to believe he is a superior intellect. What a joke. You are the master, message board patent expert. lol You complicate the issue here with all your mental masterbation.
Here's the deal dopey donk. Insiders own a ton of stock here. But, no one can monitize any of it until stock maintains much higher price and volume. Management, the Italians, the Korean, all share a common goal with retail...................higher prices with much greater liquidity. Or else, no one wins. Is that too simple for you numb nuts..........????
"It's sometimes challenging to figure our where you stand"
Now thats funny. Maybe, if no one can figure out what our uber intellectual, message board patent attorney is saying, he isnt saying anything. His posts are meant to confuse, because he has no consistent message. "Retail holders might make money, but not too much, or maybe alot, or maybe loss all as insiders and MM's steal everything." He is as useless as #$%$ on a bull.
Donk is like all academics, they pontificate ad nausum but have so little experience in the private sector and so little skin in the game, nothing they say is actionable in the real world. Go Donk
Reseller, can you be more stupid? A trend, by definition, is NOT a one or 2 day temporary spike. Stock, going to .22 for a nanosecond got you all hot and bothered, but means nothing.
VASO needs a new mouthpiece. Needs a new CEO.
This is their p2 results. Sno might know better, but % is impressive but we dont know the size or severity of the lesions. It might just have been an easier wound to treat than what rgrx went after. Not a primary focus for us right now but sure like their valuation.
In the Phase II trial, SD-101 application resulted in closure of 85% of target chronic lesions, in addition to a 55% reduction in BSA coverage of lesions and erosions. SD-101 was well tolerated by the children, with daily administration up to 3 months
You can not think that that nonsense posted by donk will, for one second, delay or cancel the trials upcoming. (and that is the only thing that would justify selloff) GTREE's entire business plan, entire platform, total existence, is based on rgrx's drug , Thymosin beta 4. They have taken millions from the Korean government based on the promise and potential of Thymosin beta 4. Patent portfolio is the same now as it was when Gtree signed on. Its the nature of the beast at rgrx to keep pursuing more patents, and they will come way before trials end.
Trials starting in Sept will punish the short so must spread a little fear here(and not hard in this market) to cover. All noise. RGRX remains the same dispite the machinations; still AON.
Again, market and sector getting killed and OAS is rallying to highs of the day. Options very expensive. Could be the first of the e&p's to go. Someone has to be first.......................
That would be tragic. But, who knows with this company
Some nice stock done on the offer, but it just cant sustain any rally. Yet, it doesnt sell off either. The times i have seen this action, stock usually gets everyone so frustrated, and then takes off. But, this is vaso, so...........
Sno, you and donk are the ones with the known unknown agenda. You constant crying and negative bias in front of a critical month is typical for you. No one is hiding anything from you. Trials designs will be at the government site when they are ready and approved by the FDA. And that is up to Ora and the koreans and fda. I dont believe that "reuters" post the other day. It had no reaction on stock price, wasnt PR'd by JJ, and wasnt on english Gtree site. Maybe koreans are getting a little ahead of themselves assuming imminent fda approval or wasnt a real rueter post. I dont know. But, JJ aint holding anything back. He wants stock price higher than anyone. He is looking for a payday to. So, just cool your jets. Your position is smaller than most here.
And donk/? He shows up and stock starts to fall, and he hits us with patent "expertise". F him. A tool of the shorts to get everyone to run for the hills. Totally misses the big picture here.
Market is tragic and rgrx was susceptible to negative talk as it has held up like a champ. Few pennies wont matter much soon. Till then, read the funny papers if you like(donk and sno), but give them little cred.
The ONLY biotech that has not been effected by ibb and market meltdown. It held up and now is moving up. That type of positive divergence usually means very good things. Amgn buyout? Why spend more on milestones if they know heart drug is working. And only they would know. Huge revenue stream if drug successful. They get ALS as a bonus....